Drugs that contain Capecitabine
1. Xeloda patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5472949 | CHEPLAPHARM | N4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same |
Dec, 2013
(10 years ago) | |
|
US5472949 (Pediatric) | CHEPLAPHARM | N4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same |
Jun, 2014
(9 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-131) | Dec 10, 2016 |
| Pediatric Exclusivity(PED) | Jun 10, 2017 |
Market Authorisation Date: 30 April, 1998
Treatment: Method of treating tumors
Dosage: TABLET;ORAL
How can I launch a generic of XELODA before it's drug patent expiration?
More Information on Dosage
XELODA family patents
